Abstract Details
|
Oscar L. Lopez, MD, FAAN
PRESENTER |
Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acumen. |
| No disclosure on file | |
| Alexis M. Steinberg, MD | The institution of Dr. Steinberg has received research support from University of Pittsburgh Clinical and Translational Institute (CTSI). |
| James T. Becker, PhD (University of Pittsburgh) | No disclosure on file |
| Robert A. Sweet | Robert A. Sweet has nothing to disclose. |
| Sarah Berman, MD (University of Pittsburgh) | The institution of Dr. Berman has received research support from NIH. |
| Eric M. McDade, DO (Washington University At St. Louis School of Medicine) | Dr. McDade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. McDade has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alzamend. Dr. McDade has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fondation Alzheimer. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. The institution of Dr. McDade has received research support from NIA. The institution of Dr. McDade has received research support from Eli Lilly. The institution of Dr. McDade has received research support from Hoffman-La Roche. The institution of Dr. McDade has received research support from Eisai. The institution of Dr. McDade has received research support from Eisai. Dr. McDade has received intellectual property interests from a discovery or technology relating to health care. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board Member with Fondation Alzheimer. |
| No disclosure on file | |
| M. I. Kamboh | No disclosure on file |
| William E. Klunk, MD, PhD (Western Psychiatric Institute and Clinic) | No disclosure on file |